Media Database
>
Jeff Overley

Jeff Overley

Editor At Large at Law360

Contact this person
Email address
j*****@*******.comGet email address
Influence score
53
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Law
  • Politics

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

law360.com

Judiciary Panel Eyes Rules For Class Cert., Litigation Funding

Federal judiciary advisers set the stage Friday for new and far-reaching rules involving two sets of highly contentious topics: long-simmering demands for greater transparency in third-party litigation funding and calls for closer scrutiny of class action issues, including payouts to class counsel, certification standards and financial perks for plaintiffs.
law360.com

Tom Goldstein Can't Pay Attys With 'Tainted Funds,' DOJ Says

Indicted appellate luminary Tom Goldstein cannot cover his legal bills by selling his multimillion-dollar home, because it's a "tainted asset" worth "far less" than his attorney fees, the U.S. Department of Justice said in a blistering court filing, adding that Goldstein may flee the country as his reputation and marriage collapse.
law360.com

9th Circ. Axes Ruling Trader Joe's 'Weaponized Legal System'

A California federal judge hastily found that Trader Joe's cooked up borderline-frivolous theories of trademark infringement to punish union organizers, the Ninth Circuit held Monday, finding that union merchandise looks "strikingly similar" to the grocer's well-known logo.
law360.com

DOJ Throws Lifeline To J&J At 3rd Circ. After $1.6B FCA Loss

A district judge made multiple errors in an opinion and jury instructions underpinning a staggering False Claims Act verdict tied to Johnson & Johnson's drug marketing practices, and a fresh look is needed "under a correct view of the law," the U.S. Department of Justice told the Third Circuit on Wednesday.
law360.com

DOJ Throws Lifeline To J&J At 3rd Circ. After $1.6B FCA Loss

A district judge made multiple errors in an opinion and jury instructions underpinning a staggering False Claims Act verdict tied to Johnson & Johnson's drug marketing practices, and a fresh look is needed "under a correct view of the law," the U.S. Department of Justice told the Third Circuit on Wednesday.
law360.com

Loper Bright Neutered In 6th Circ., Tenn. Tells Supreme Court

There is "growing confusion among the circuits" regarding the U.S. Supreme Court's rejection of judicial deference to regulators, as evidenced by a Sixth Circuit ruling that negates much of the high court's Loper Bright ruling, Tennessee told the justices in a new petition.
law360.com

6th Circ. Rips 'Stalking Horse' Ploy In Drug Negotiation Suit

The pharmaceutical industry will feel the sting of a Wednesday loss in a wide-ranging war over Medicare's power to negotiate drug prices, as the Sixth Circuit tossed a suit and accused one major company of utilizing a "stalking horse" to sue in a more favorable forum.
law360.com

Key Opioid Theory Actually Irrelevant, Drug Cos. Tell 4th Circ.

With federal judges in West Virginia suddenly split over the central legal theory in opioid litigation, major drug distributors are insisting the theory actually doesn't matter, telling the Fourth Circuit it can uphold their triumph in a landmark trial without even touching the hot-button issue.
law360.com

6th Circ. Rips 'Stalking Horse' Ploy In Drug Negotiation Suit

The pharmaceutical industry will feel the sting of a Wednesday loss in a wide-ranging war over Medicare's power to negotiate drug prices, as the Sixth Circuit tossed a suit and accused one major company of utilizing a "stalking horse" to sue in a more favorable forum.
law360.com

​In New Twist, W.Va. Judges Suddenly At Odds In Opioid Suits

A new ruling in West Virginia opioid crisis litigation is revealing sharp divisions among the Mountain State's federal judges regarding a pivotal legal theory, potentially boosting a Fourth Circuit appeal by beleaguered municipalities aiming to erase a landmark win for drug distributors.
law360.com

FCA Draws Heavy Constitutional Fire After $1.6B J&J Verdict

Reeling from a record fraud verdict tied to drug promotion practices, Johnson & Johnson is pursuing a sweeping constitutional challenge to the False Claims Act, and in filings this week at the Third Circuit, major industry allies rallied behind its views of whistleblower litigants usurping executive branch power.
law360.com

FCA Draws Heavy Constitutional Fire After $1.6B J&J Verdict

Reeling from a record fraud verdict tied to drug promotion practices, Johnson & Johnson is pursuing a sweeping constitutional challenge to the False Claims Act, and in filings this week at the Third Circuit, major industry allies rallied behind its views of whistleblower litigants usurping executive branch power.
law360.com

How GOP Judges Teed Up 4th Circ.'s Supreme Court Shutout

No appeals court found the U.S. Supreme Court's latest term less endearing than the Fourth Circuit, where a supersize shutout accentuated a multiyear slump for the once-favored circuit and repeatedly vindicated conservative dissenters on the left-leaning bench.
law360.com

Circuit-By-Circuit Recap: Justices Send Message To Outliers

It was a tough term at the U.S. Supreme Court for two very different circuits — one solidly liberal, one solidly conservative — that had their rulings overturned in eye-popping numbers. But it was another impressive year for a relatively moderate circuit that appears increasingly simpatico with the high court.
law360.com

Circuit-By-Circuit Recap: Justices Send Message To Outliers

It was a tough term at the U.S. Supreme Court for two very different circuits — one solidly liberal, one solidly conservative — that had their rulings overturned in eye-popping numbers. But it was another impressive year for a relatively moderate circuit that appears increasingly simpatico with the high court.
law360.com

Circuit-By-Circuit Recap: Justices Send Message To Outliers

It was a tough term at the U.S. Supreme Court for two very different circuits — one solidly liberal, one solidly conservative — that had their rulings overturned in eye-popping numbers. But it was another impressive year for a relatively moderate circuit that appears increasingly simpatico with the high court.
law360.com

The Funniest Moments Of The Supreme Court's Term

After justices and oral advocates spent much of an argument pummeling a lower court's writing talents, one attorney suggested it might be time to move on — only to be told the drubbing had barely begun. Here, Law360 showcases the standout jests and wisecracks from the 2024-25 U.S. Supreme Court term.
law360.com

The Funniest Moments Of The Supreme Court's Term

After justices and oral advocates spent much of an argument pummeling a lower court's writing talents, one attorney suggested it might be time to move on — only to be told the drubbing had barely begun. Here, Law360 showcases the standout jests and wisecracks from the 2024-25 U.S. Supreme Court term.
law360.com

Justices Punt La. Voting Rights Case Despite Thomas Dissent

The U.S. Supreme Court surprisingly declined Friday to resolve a yearslong saga over voting rights and alleged racial gerrymandering, ordering new arguments over Louisiana's controversial congressional districts despite an impassioned protest from Justice Clarence Thomas.
law360.com

'Forum Shopping' Center Stage At 6th Circ. Drug Pricing Args

As part of an expansive effort to tee up U.S. Supreme Court review, pharmaceutical industry-backed opponents of Medicare's drug price negotiations entered less-than-hospitable territory at the Sixth Circuit, where judges pointedly questioned a local business group's basis for challenging a national healthcare program.
law360.com

'Forum Shopping' Center Stage At 6th Circ. Drug Pricing Args

As part of an expansive effort to tee up U.S. Supreme Court review, pharmaceutical industry-backed opponents of Medicare's drug price negotiations entered less-than-hospitable territory at the Sixth Circuit, where judges pointedly questioned a local business group's basis for challenging a national healthcare program.